Skip to content
Use caution Drug recall · FDA · Published October 30, 2015

Avantor Recalls Magnesium Sulfate Due to Impurity Failures

Avantor recalls 265 drums of Magnesium Sulfate 7-Hydrate for parenteral use due to failed impurity specifications. Check lot numbers 0000115590 and 0000117563.

🇺🇸 FDA recall #D-0563-2016DrugAvantor Performance Materials ›
Take action

Contact the company

Recalling firmAvantor Performance Materials Inc3477 Corporate Parkway · Center Valley, PA 18034
✎ GovInfoNow plain-language explainer

What happened, in plain English

Avantor Performance Materials Inc is recalling Magnesium Sulfate 7-Hydrate intended for parenteral use because it failed to meet impurity specifications. The product was distributed in the US (including CA, IL, and NC) and Canada. No specific remedy or injury details are provided in the record. Read more at govinfonow.com/recall/43411-avantor-performance-materials-inc-recalls-magnesium-sulfate-7-hydrate-for.

Source Summary by GovInfoNow · govinfonow.com/recall/43411-avantor-performance-materials-inc-recalls-magnesium-sulfate-7-hydrate-for · Updated October 11, 2026 · FDA enforcement record: FDA #D-0563-2016

Cite this page

“Avantor Recalls Magnesium Sulfate Due to Impurity Failures.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43411-avantor-performance-materials-inc-recalls-magnesium-sulfate-7-hydrate-for. Based on FDA recall #D-0563-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0563-2016%22&limit=1).

Why it’s dangerous

The product failed impurity specifications, meaning it contained out-of-specification levels of impurities. For a drug intended for injection (parenteral use), such deviations can potentially compromise safety and efficacy, though the specific health consequences are not described in the record.

Who’s affected

Healthcare facilities or professionals who purchased this specific pharmaceutical-grade chemical for parenteral use between the manufacturing date and the expiry of May 10, 2017. The record does not specify which patients were at risk.

How to tell if you have this one

Look for Magnesium Sulfate 7-Hydrate labeled 'For Parenteral Use' from Avantor Performance Materials Inc. Check if the lot number is 0000115590 or 0000117563, both with an expiry date of 5/10/17. The product was sold in 100LB drums.

  • Brand
    Avantor Performance Materials
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify the Product

    Verify if you have Magnesium Sulfate 7-Hydrate from Avantor Performance Materials Inc with lot numbers 0000115590 or 0000117563.

  2. Contact the Manufacturer

    Call Avantor Performance Materials Inc at 610-573-2600 for further instructions, as no specific remedy is listed in the recall record.

Where it went and when

Where it was distributed

Distributed in 3 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed in the US including: CA, IL & NC; Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Illinois, North Carolina.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Oct 30, 201512. FDA classified it Class III: Jan 6, 201623. Published in FDA’s Enforcement Report: Jan 13, 201634. FDA terminated the recall: Dec 19, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product sold?

It was distributed in the US, including California, Illinois, and North Carolina, as well as Canada.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0563-2016 (October 30, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0563-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA